| GOLDMAN SACHS EMERGING MARKETS EQUITY PORTFOLIO IX USD MDIS | RVI EMERGENTES | 8,718357 | 01/10/2026 | 24,02% | 51,17% | ** |
| BNY MELLON GLOBAL EMERGING MARKETS OPPORTUNITIES FUND GBP (ACC) GBP | RVI EMERGENTES | 3,716397 | 01/10/2026 | 24,01% | 52,61% | * |
| MULTIUNITS LUX - AMUNDI CORE NASDAQ-100 SWAP UCITS ETF ACC EUR | RVI GLOBAL | 109,048613 | 30/09/2026 | 24,01% | 95,49% | ***** |
| UBS MSCI JAPAN SELECTION INDEX FUBD CHF I-A ACC | RVI JAPÓN | 1.682,517409 | 30/09/2026 | 24,01% | 66,10% | ** |
| BBVA MEGATENDENCIA TECNOLOGIA, FI A | RVI TECNOLOGÍA | 62,658828 | 30/09/2026 | 24,00% | 82,49% | ** |
| FIDELITY FUNDS-JAPAN VALUE A2-DIST-JPY | RVI JAPÓN VALOR | 64,135806 | 01/10/2026 | 24,00% | · | ND |
| SABADELL BOLSAS EMERGENTES, FI BASE | RVI EMERGENTES | 24,296712 | 30/09/2026 | 24,00% | 56,71% | ** |
| T.ROWE US LARGE CAP VALUE EQUITY FUND S | RVI USA | 11,417950 | 01/10/2026 | 23,99% | · | ND |
| AMUNDI JAPAN TOPIX UCITS ETF DAILY EUR HEDGED CAP | RVI JAPÓN | 638,085600 | 01/10/2026 | 23,98% | 97,39% | ***** |
| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) GBP (HEDGED) | RVI BIOTECNOLOGÍA | 163,646586 | 01/10/2026 | 23,98% | 46,04% | *** |
